Cost-Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia In Portugal
Value Health
.
2014 Nov;17(7):A532.
doi: 10.1016/j.jval.2014.08.1693.
Epub 2014 Oct 26.
Authors
M Augusto
1
,
M Gouveia
2
,
M Borges
3
,
M Campioni
4
Affiliations
1
Evigrade, Health Care Research and Consulting, Lda, Lisboa, Portugal.
2
Católica Lisbon School of Business and Economics, Lisbon, Portugal.
3
University of Lisbon, Lisbon, Portugal.
4
Amgen (Europe) GmbH, Zug, Switzerland.
PMID:
27201694
DOI:
10.1016/j.jval.2014.08.1693
No abstract available